Amy GilesIncreasing Engagement
Bud BilanichSuccess Coach
Matt TurnerPatient Affordability
Paul TheisenPatient Acquisition
David LinetskyPoint-of-Care Marketing
Matthew DurhamOmnidynamic Marketing
Brenda SnowAuthentic Patient Voice
Liz KaneImpactful Strategy
Frank BurrellScientific Storytelling
Suma Ramadas, PhDMedical Affairs
Stacey GandlerBrand Nourishment
Daniel SontupeMarket Access
Pat PurcellMeeting Engagement
Joey CohenMedication Adherence
Exclusive worldwide license to lentiviral vector gene therapy constitutes the first transaction of Axovant’s ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email